Álvaro Núñez

🚨STABLECOIN USAGE SURGING BUT MARKET CAP MAY NOT FOLLOW JPMorgan says stablecoin transaction volume is running at a ~$17.2T annualized pace in 2026, with adoption accelerating after the GENIUS Act helped unlock institutional use. But analysts warn higher payment efficiency and rising velocity could limit market cap growth even if usage expands rapidly. The stablecoin market currently stands near $322B, led by $USDT ($189B) and $USDC ($77B).

Here are the Top 5 Most Traded Assets from the DeFiLlama Markets Rankings: 1. S&P 500 (xyz:sp500) 2. Crude Oil - WTI (xyz:cl) 3. XYZ100 Equity Index (xyz:xyz100) 4. Crude Oil - Brent (xyz:brentoil) 5. Gold (xyz:gold)

UK Instant Payments Network Policy Adjustment Triggers Migration Away from Hgih-Value Settlement System : Research crowdfundinsider.com/2026/04/276292…

Stablecoins just beat the entire US banking payment system in monthly transaction volume. $7.2 TRILLION. in one month. and most people still think they're just a place to park money between trades 😭 The new episode of @web3quickbites breaks it all down, what's actually happening, who's building on stablecoin rails, and why 2026 is the real turning point. no hype. just the full picture, including the parts that still don't work. 🎙️ [Link in the comments for full episode] rt if your timeline needs this 👇

⚡️ UPDATE: Stripe introduces agent wallet allowing AI agents to make payments without exposing user credentials.

HUGE! Meta just rolled out stablecoin payments for creators. If this roles out site wide, 3.58B daily active users becomes the new TAM.

Leí el reporte Q1 2026 de Morpho para que tú no tengas que hacerlo. Los 5 datos que importan: 1. Market share récord: 11.95% (le están quitando terreno a Aave trimestre tras trimestre) 2. RWAs crecieron 47x en un año: de $8M a $368M en colateral 3. Ya hay 3 índices del S&P 500 tokenizados disponibles como colateral 4. Custodios institucionales (Fireblocks, Anchorage, Taurus) ya integraron Morpho 5. Morpho Midnight: préstamos a tasa fija. Apuntan al mercado global de crédito de $200 trillones, no al de $60B respaldado por cripto. Cuando crees que ya no hay calidad en las criptomonedas, simplemente no estas buscando bien.

OPINION: The age of Agentic Commerce has arrived, and @Consensus2026 is where you can experience it IRL. Ivan Castano Freeman on why the protocols being debated in Miami could define the rails that trillions in machine-to-machine transactions run on. coindesk.com/opinion/2026/0…

Your credit score says one thing. Your assets say another. So why does lending still ignore wealth, move slowly, and rely on outdated infrastructure? On Fintech OGs, Mike Taormina, CFA and Ian Lampl unpack what it really takes to build lending businesses through multiple market cycles. They cover: -How lending scales through funding constraints. -Why credit models still miss real collateral. -Where AI can improve lending workflows. -How stablecoins could reshape financial infrastructure. -Why crypto-backed loans may unlock smarter credit decisions. If you care about fintech, lending, payments, digital assets, or the future of financial services, this one is for you. The full episode is out now 👇 Powered by @spadedata. This episode is sponsored by @meetgranola.

Ripple Custody "...on a tear..." -KBank -Kyobo Life -BBVA -Intesa Sanpaolo -AMINA Bank -+MORE

Sergey explains how Chainlink enables users to achieve their desired level of decentralization, which Eric Schmidt calls a whole new industrial system “Chainlink oracle networks create large committees of identified nodes, where you can choose the decentralization that you want to achieve” “If you want a network of 100 nodes to do a very specific computation for you, you can choose the 100 nodes, you can choose the jurisdiction they're in, you can choose the trust assumptions you want to have with them, you can choose their commitment to you, and those are all choices you should be able to make and to create that type of decentralization in a very explicit way” Eric Schmidt: “I think you've just described a whole new industrial system that's not very well understood outside of this room”

🚨 NEW BITCOIN WALLET CLAIMS QUANTUM RESISTANCE Postquant Labs says its new Layer 2 design shrinks quantum attack window to ~20 minutes or 2 blocks. This delivers protection without altering the base protocol unlike challenging proposals of BIP-361 and Paul Sztorc’s hard fork.

🔥 BIG! Tokenized U.S Treasuries on $XRP ledger have pulled an 8x move in a single year 👏 just the beginning! 🤝🏻

🔥 JUST IN: $4.7T State Street plans to launch tokenized fund servicing from Luxembourg by year-end.

$XLM KEEPS GIVING ME REAL REASONS TO STAY CONVICTED 👇 Stellar renewed with MoneyGram for 5 more years as the partnership expands into El Salvador. Faster, lower-cost cross-border transfers are still one of the clearest use cases in crypto. Bullish!

Visa, Stripe, Coinbase, JP Morgan - everyone’s hedging their bets as agentic rails reshape commerce. Discover how to integrate into both legacy and machine-to-machine economies in my new article. buff.ly/bHzeOCW

Finance is entering its tokenized era. In the past week, moves from J.P. Morgan, the ECB, Coinbase, and Tether showed tokenization is being built into the plumbing of global finance. Latest tokenization news ↓ 1️⃣ J.P. Morgan says tokenization will drive change across entire funds industry Tokenization of ETFs could improve creation and redemption while ushering in “near-instant settlement” and nonstop access. theblock.co/post/398876/jp… 2️⃣ Coinbase lists first GBP stablecoin The stablecoin listing comes just days after Coinbase began letting UK customers borrow against their crypto. finextra.com/newsarticle/47… 3️⃣ ECB inks deals with standard setters to smooth digital euro rollout The European Central Bank has signed agreements with three standard setters as it looks to minimize costs and encourage coordination. finextra.com/newsarticle/47… 4️⃣ Tether backs UAE tokenization firm KAIO to bring Emirati funds onchain KAIO plans to expand into credit, structured investments, and exchange-traded funds, aiming to lower investor barriers to entry. coindesk.com/business/2026/… 5️⃣ DTCC publishes deep dive on what tokenization means for everyday investors The U.S. securities settlement giant (which clears ~99% of U.S. equities) outlines real-world benefits: fractional ownership, extended/24/7 trading hours, real-time settlement, and lower costs. Positions tokenization as moving from institutional experiment to retail-accessible infrastructure. dtcc.com/dtcc-connectio…

One European bank has plans to build on-chain equity infrastructure by year-end. @WhiteBit Deputy CCO Vlad Maltsev tells @2084Richardson traditional exchanges are prepping for 24/5 — eventually 24/7 — trading at @ParisBlockWeek x.com/BitcoinNews/st…

This isn’t just a war. It’s the biggest global energy shock in history. Nasser Saidi explains how disrupted oil flows, inflation, and food insecurity are exposing the fragility of the global economy. As risks around the dollar rise, the world is pivoting toward China & Asia. Who withstands the shock, and who doesn’t? Watch the full episode: youtu.be/-kw0P_3Rikw #Forbes @Nasser_Saidi @MousaSally

Bio Protocol designed a novel ADHD drug candidate in 24 hours using AI. First lab test: $500. Full validation: ~$1,500. Pharma spends millions and years to reach the same point. That changes what DeSci can do. Drug development has always been gated by capital, not science. Research gets funded when it aligns with commercial priorities. Plenty of valuable questions never get asked because no one with the budget chose to ask them. DeSci has been working on that gap for years, but the ambition stayed kneecapped by the cost of discovery itself. AI changes the math. With costs this low, a DAO treasury can fund a drug candidate all the way validation with real lab data. Entire categories of research pharma was NEVER going to touch are now within reach. Yet, three problems persister that AI + community funding can't clear alone: - Data inaccessibility: the training data AI needs to validate further sits locked inside pharma companies that treat it as a competitive weapon (Bio and Molecule are building to solve this via Science Beach and other initiatives) - Wet labs: even a well-characterized candidate needs physical validation on biological material. No amount of AI removes this step - Clinical trials: testing on humans still runs on the old capital structure — tens of millions to hundreds of millions. Nothing in the DeSci stack reaches that far yet DeSci gets candidates to the START of that path with something real in hand: a characterized compound with published binding data and a permanent record. That's a different conversation with pharma than a hypothesis and a pitch. There's a cultural current underneath all of this. People using AI to fight their own cancer, treat their pets, research conditions pharma deprioritized. A growing cohort motivated by personal stakes, not commercial ones. DeSci pairs cleanly with this trend, giving hope that personal motivation, not profit, can soon play a larger role in discovery.